KATHARINE SHIELDS: Open Payments
NPI 1588210850 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,221 in 190 payments from 18 companies in 2025. Trend: 2023 $3,025 · 2024 $4,146 · 2025 $3,221
Food & beverage: $3,121Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 37 | $561 |
| Janssen Biotech, Inc. | 24 | $455 |
| ABBVIE INC. | 16 | $316 |
| UCB, Inc. | 12 | $234 |
| Novartis Pharmaceuticals Corporation | 13 | $214 |
| LEO Pharma Inc. | 8 | $214 |
| GENZYME CORPORATION | 8 | $213 |
| Galderma Laboratories, L.P. | 4 | $163 |
| E.R. Squibb & Sons, L.L.C. | 21 | $150 |
| PFIZER INC. | 8 | $140 |
Products named: OPZELURA, TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, ADBRY, COSENTYX, Sotyktu.
Industry payments across NY — which companies pay providers there.
